DE68908913D1 - Faktor XIII zur Vorbeugung von intraventrikulären Blutungen. - Google Patents

Faktor XIII zur Vorbeugung von intraventrikulären Blutungen.

Info

Publication number
DE68908913D1
DE68908913D1 DE89102471T DE68908913T DE68908913D1 DE 68908913 D1 DE68908913 D1 DE 68908913D1 DE 89102471 T DE89102471 T DE 89102471T DE 68908913 T DE68908913 T DE 68908913T DE 68908913 D1 DE68908913 D1 DE 68908913D1
Authority
DE
Germany
Prior art keywords
prevention
factor xiii
intraventricular
bleeding
intraventricular bleeding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE89102471T
Other languages
English (en)
Other versions
DE68908913T2 (de
Inventor
Akira Shirahata
Minoru Uchida
Satoshi Tanaka
Kenichiro Tsumura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Publication of DE68908913D1 publication Critical patent/DE68908913D1/de
Application granted granted Critical
Publication of DE68908913T2 publication Critical patent/DE68908913T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE89102471T 1988-02-24 1989-02-14 Faktor XIII zur Vorbeugung von intraventrikulären Blutungen. Expired - Lifetime DE68908913T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63039646A JPH01216939A (ja) 1988-02-24 1988-02-24 末熟児頭蓋内出血阻止剤

Publications (2)

Publication Number Publication Date
DE68908913D1 true DE68908913D1 (de) 1993-10-14
DE68908913T2 DE68908913T2 (de) 1994-01-27

Family

ID=12558846

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89102471T Expired - Lifetime DE68908913T2 (de) 1988-02-24 1989-02-14 Faktor XIII zur Vorbeugung von intraventrikulären Blutungen.

Country Status (12)

Country Link
US (1) US5114916A (de)
EP (1) EP0330049B1 (de)
JP (1) JPH01216939A (de)
KR (1) KR0137476B1 (de)
AT (1) ATE94070T1 (de)
AU (1) AU613154B2 (de)
CA (1) CA1332352C (de)
DE (1) DE68908913T2 (de)
DK (1) DK174978B1 (de)
ES (1) ES2059588T3 (de)
IE (1) IE63656B1 (de)
PT (1) PT89802B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
AU3423493A (en) * 1991-12-31 1993-07-28 Zymogenetics Inc. Methods and compositions for reducing blood loss
EP0598133B1 (de) * 1992-04-21 2000-03-29 Ajinomoto Co., Inc. Wundheilmittel
DE69326349T2 (de) * 1992-11-12 2000-03-02 Zymogenetics Inc Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen
JPH07328108A (ja) * 1994-06-10 1995-12-19 Ajinomoto Co Inc 生体組織接着剤及び血液凝固剤
DE69943205D1 (de) 1998-08-06 2011-03-31 Mountain View Pharmaceuticals Peg-uricase Konjugate und Verwendung davon
WO2006021584A2 (en) * 2004-08-27 2006-03-02 Novo Nordisk Health Care Ag Purification of factor xiii polypeptides from biological materials
US8461302B2 (en) * 2004-11-23 2013-06-11 Zymogenetics, Inc. Purification of recombinant human factor XIII
CA2604399A1 (en) 2005-04-11 2006-10-19 Savient Pharmaceuticals, Inc. Variant forms of urate oxidase and use thereof
TWI418564B (zh) * 2005-04-11 2013-12-11 Savient Pharmaceuticals Inc 利用陽離子界面活性劑之蛋白質純化
US9534013B2 (en) * 2006-04-12 2017-01-03 Horizon Pharma Rheumatology Llc Purification of proteins with cationic surfactant
KR101861547B1 (ko) 2009-06-25 2018-07-02 크레알타 파마슈티칼스 엘엘씨 페길화된 유리카아제 치료 중에 혈청 요산을 모니터링하여 주입 반응의 위험성 및 반응의 항체­매개 상실을 예측하는 방법 및 키트

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717708A (en) * 1968-10-24 1973-02-20 Cutter Lab Blood coagulation complex
DE2063070C3 (de) * 1970-12-22 1975-07-24 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Arzneimittels mit fibrinstabilisierender Wirkung
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
DK175919B1 (da) * 1986-09-19 2005-06-27 Univ Washington Ekspression af biologisk aktiv faktor XIII

Also Published As

Publication number Publication date
JPH0378850B2 (de) 1991-12-17
PT89802A (pt) 1989-10-04
ATE94070T1 (de) 1993-09-15
DK174978B1 (da) 2004-04-05
PT89802B (pt) 1994-04-29
EP0330049B1 (de) 1993-09-08
JPH01216939A (ja) 1989-08-30
IE890580L (en) 1989-08-24
KR0137476B1 (ko) 1998-06-01
KR890012659A (ko) 1989-09-18
AU3024389A (en) 1989-08-24
DK83889A (da) 1989-08-25
AU613154B2 (en) 1991-07-25
CA1332352C (en) 1994-10-11
US5114916A (en) 1992-05-19
EP0330049A3 (de) 1991-01-30
ES2059588T3 (es) 1994-11-16
DK83889D0 (da) 1989-02-23
IE63656B1 (en) 1995-05-31
EP0330049A2 (de) 1989-08-30
DE68908913T2 (de) 1994-01-27

Similar Documents

Publication Publication Date Title
DE3872372D1 (de) Zusammensetzung zur erhoehung der intrazell-atp-spiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.
NO905264L (no) Fremgangsmaate for fremstilling av biologisk aktivt protein
ATE103914T1 (de) Neue thienylcarbonsaeureester von aminoalkoholen, ihre quaternierungsprodukte sowie die herstellung und verwendung dieser verbindungen.
DE3587941T2 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
DE68908913T2 (de) Faktor XIII zur Vorbeugung von intraventrikulären Blutungen.
DE3784693D1 (de) Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.
NO893637D0 (no) Fremgangsmaate for aa stabilisere blodkoagulasjonsfaktorer.
ES2073425T3 (es) Una nueva glicoproteina de tipo trombomodulina susceptible de ser obtenida a partir de la orina.
DE68918778T2 (de) Verfahren zur Herstellung von ungesättigte Lactone enthaltenden Gemischen, hierdurch hergestellte Verbindungen und organoleptische Verwendung dieser Verbindungen.
DK314487D0 (da) Benzoxepinderivat
DE3869230D1 (de) Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin.
ES2032896T3 (es) Procedimiento para la preparacion de cristales mixtos a base de insulina y derivados de insulina.
ES2073391T3 (es) Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre.
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
MX12192A (es) Composicion farmaceutica para reducir o impedir las arritmias
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
DK417889D0 (da) Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme
KR910016339A (ko) Pp4-델타, 이의 제조방법 및 용도
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition